Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles-Reference-Cited by-同舟云学术

Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles

Published:2016-08 Issue: Volume:235 Page:268-275
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lin Chin-Yu,Perche Federico,Ikegami Masaru,Uchida Satoshi,Kataoka Kazunori,Itaka Keiji^ORCID

Funder

Japanese Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference24 articles.

1. Neurological disorders: two sides to beta-amyloid;Jones;Nature reviews. Neuroscience,2012

2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics;Hardy;Science,2002

3. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective;Tanzi;Cell,2005

4. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo;Klyubin;Nat. Med.,2005

5. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function;Huang;J. Biol. Chem.,2006

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

2. Therapeutic nucleic acids in regenerative medicine and tissue repair;Nano Research;2024-07-13

3. Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease;Frontiers in Pharmacology;2024-05-24

4. Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound;Nanomaterials;2024-01-30

5. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease;Pathology - Research and Practice;2024-01